Recap: Agilent Technologies Q3 Earnings

Shares of Agilent Technologies A fell 0.6% in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share were up 41.03% year over year to $1.10, which beat the estimate of $0.99.

Revenue of $1,586,000,000 rose by 25.77% year over year, which beat the estimate of $1,540,000,000.

Guidance

Q4 EPS expected between $1.15 and $1.18.

Q4 revenue expected to be between $1,630,000,000 and $1,660,000,000.

Conference Call Details

Date: Aug 17, 2021

Time: 04:30 PM

ET Webcast URL: https://event.on24.com/eventRegistration/EventLobbyServlet?target=reg20.jsp&referrer=https%3A%2F%2Fwww.investor.agilent.com%2F&eventid=3190663&sessionid=1&key=B5CA9083735D727B3F9803B404F9885E&regTag=&V2=false&sourcepage=register

Recent Stock Performance

Company's 52-week high was at $162.52

52-week low: $94.53

Price action over last quarter: Up 20.86%

Company Overview

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2020 sales), cross lab (36% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Just over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (33%) and China (20%) representing the largest country concentrations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!